• Company
    • Overview
    • Management
    • Board of Directors
    • Advisory Board
    • Compliance and Ethics
    • We Care
  • Metabolic Acidosis & CKD
    • About Metabolic Acidosis
    • About CKD
  • Veverimer
    • About Veverimer
    • Expanded Access
  • News
  • Investors
    • Overview
    • Presentations & Events
    • SEC Filings
    • Governance
    • Annual Report & Proxy
    • Stock
    • Analyst Coverage
    • Contact IR
  • Careers
    • Life at Tricida
    • Benefits
    • Job Opportunities
    • Transparency in Coverage Rule
  • Contact
  • About Veverimer
  • Expanded Access
Expanded Access

Expanded access, also known as compassionate use, may be an option for a limited number of individuals with serious or life-threatening conditions, and who have exhausted all available medical options and who do not qualify for clinical trials. Tricida may provide access to its investigational drugs to patients who meet specific criteria through expanded access. Currently we do not have an expanded access program or compassionate use program for our investigational product.

  • Privacy Policy
  • Terms
  • Forward Looking Statement
  • Site Map
  • Company
  • Metabolic Acidosis & CKD
  • Veverimer
  • News
  • Investors
  • Careers
  • Contact
HEADQUARTERS
Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA 94080
(415) 429-7800
© Tricida, Inc. All rights reserved.